PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Visit https://www.peervoice.com/KJE860 to view the entire programme with slides. After completing “Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations”, participants will be able to: Describe the rationale for intratumoural administration of oncolytic immunotherapies for skin cancer; Discuss the technical and practical considerations for intratumoural administration of oncolytic immunotherapies; and Identify oncolytic immunotherapies in development for skin cancer.